Pheton Holdings PE Ratio 1970-1969 | PTHL
Current and historical p/e ratio for Pheton Holdings (PTHL) from 1970 to 1969. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Pheton Holdings PE ratio as of November 22, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Pheton Holdings PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-11-21 | 4.74 | inf |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.031B | $0.000B |
Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product includes Beijing Feitian's Treatment Planning System. Pheton Holdings Ltd is based in BEIJING, China. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $93.361B | 11.58 |
Cencora (COR) | United States | $48.280B | 17.81 |
DiDi Global (DIDIY) | China | $22.212B | 0.00 |
Natera (NTRA) | United States | $22.082B | 0.00 |
ICON (ICLR) | Ireland | $17.675B | 15.74 |
Viatris (VTRS) | United States | $15.958B | 4.92 |
Avantor (AVTR) | United States | $14.143B | 21.20 |
Revvity (RVTY) | United States | $13.634B | 23.68 |
CochLear (CHEOY) | Australia | $12.777B | 0.00 |
Solventum (SOLV) | United States | $12.233B | 0.00 |
BioMerieux (BMXMF) | France | $11.895B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.498B | 29.58 |
Charles River Laboratories (CRL) | United States | $10.011B | 19.34 |
HealthEquity (HQY) | United States | $9.104B | 49.41 |
Doximity (DOCS) | United States | $8.999B | 52.97 |
Sonic Healthcare (SKHHY) | Australia | $8.862B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $6.892B | 32.08 |
Life Times (LTH) | United States | $5.081B | 33.63 |
Organon (OGN) | United States | $3.935B | 3.97 |
Sotera Health (SHC) | United States | $3.631B | 19.42 |
BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
Surgery Partners (SGRY) | United States | $2.925B | 33.35 |
Concentras Parent (CON) | United States | $2.789B | 0.00 |
PACS (PACS) | United States | $2.515B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.310B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.259B | 0.00 |
Premier (PINC) | United States | $2.195B | 11.42 |
GeneDx Holdings (WGS) | United States | $2.162B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.868B | 49.00 |
Teladoc Health (TDOC) | United States | $1.828B | 0.00 |
Progyny (PGNY) | United States | $1.315B | 26.62 |
Pediatrix Medical (MD) | United States | $1.285B | 12.57 |
CareDx (CDNA) | United States | $1.241B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.206B | 0.00 | |
AMN Healthcare Services Inc (AMN) | United States | $0.984B | 6.66 |
Embecta (EMBC) | United States | $0.797B | 5.32 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
Agilon Health (AGL) | United States | $0.779B | 0.00 |
SBC Medicals (SBC) | United States | $0.674B | 0.00 |
InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
DocGo (DCGO) | United States | $0.434B | 16.35 |
Enhabit (EHAB) | United States | $0.380B | 32.87 |
COMPASS Pathways (CMPS) | United Kingdom | $0.302B | 0.00 |
ModivCare (MODV) | United States | $0.254B | 13.79 |
LifeMD (LFMD) | United States | $0.251B | 0.00 |
Sera Prognostics (SERA) | United States | $0.221B | 0.00 |
Biodesix (BDSX) | United States | $0.186B | 0.00 |
Nutex Health (NUTX) | United States | $0.179B | 0.00 |
Beauty Health (SKIN) | United States | $0.176B | 0.00 |
MultiPlan (MPLN) | United States | $0.112B | 0.00 |
So-Young (SY) | China | $0.086B | 16.60 |
Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
OncoCyte (OCX) | United States | $0.046B | 0.00 |
NeueHealth (NEUE) | United States | $0.041B | 1.10 |
IceCure Medical (ICCM) | Israel | $0.032B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.032B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
Oncology Institute (TOI) | United States | $0.012B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
KindlyMD (KDLY) | United States | $0.006B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |